Real Estate

Biotech Resilience Anchors Boston Real Estate Amid Consumer Divergence

The continued flow of venture capital into life sciences firms confirms that while broader signs suggest a cooling in non-tech

The median home price in Massachusetts stands at $655,219, up 2.3% year-over-year, a figure that belies the intense pressure on

For investors tracking Greater Boston’s economic pulse, the signal today is one of profound divergence: while national labor metrics suggest

New Title: Boston’s Bifurcated Housing Market: Analyzing the Premiumization of Luxury Amid Affordability Crises The Great Divide in Greater Boston

The Greater Boston life sciences corridor is entering a phase of highly selective investment, where specialized biotech and pharma assets

The median home price in Massachusetts stands at $661,896, up 2.3% year-over-year, yet this single metric masks a profound divergence

The recent announcement of major infrastructure upgrades—such as the new Foxboro MBTA Station built in anticipation of the 2026 FIFA

The employment data released by the Federal Reserve Bank of Boston paints a picture not of uniform growth across New

The median home price in Massachusetts stands at $661,896, up 2.3% over the past year—a figure that belies the underlying

The contrast between a major pharmaceutical anchor opening new hubs and large tech firms initiating significant workforce reductions defines the